AnalystsMatthew StantonMatthew Stanton's Stock Forecasts
AnalystsMatthew Stanton
Analyst Ranking
Bottom 23%
#3799 out of 4871 analysts
Average Return
-29.87%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good
Matthew Stanton's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biolife Solutions IncBLFS | +28.16% | $17.51 | $22.44 | 2024-04-04 - 2025-04-03 | Strong Buy |
Matthew Stanton Analyst Color
Get additional color on Matthew Stanton's coverage of popular stocks
Matthew Stanton's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cryoport IncCYRX | 2 | Hold | $8.00 | +36.52% | Downgrades | 9 months ago |
Standard Biotools IncLAB | 1 | Strong Buy | $3.25 | N/A | Initiates Coverage On | a year ago |
Biolife Solutions IncBLFS | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | a year ago |
Azenta IncAZTA | 1 | Hold | $64.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.